John Johnson - Insider Trading & Ownership

Location: Dendreon Corporation, 1301 2 Nd Avenue, Seattle, WA
Summary: The estimated net worth of John Johnson is at least $10.6M dollars as of August 15, 2025. John Johnson is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $7.31M. John Johnson is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2.92M. John Johnson is the Director of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $265K. John Johnson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116K.
Signature: /s/ Beth Hecht, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when John Johnson files a new Insider Trading report.

Ownership of John Johnson

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
XERS	Xeris Biopharma Holdings, Inc.	Director	$7.31M	-$786K	-9.71%	Aug 13, 2025
APLT	Applied Therapeutics, Inc.	Executive Chairman, Director	$2.92M			Dec 19, 2024
AXGN	Axogen, Inc.	Director	$265K	-$43.2K	-14%	Jun 19, 2025
VSTM	Verastem, Inc.	Director	$116K			May 22, 2025
SBBP	Strongbridge Biopharma plc	Chief Executive Officer, Director				Oct 5, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.